Westfield Capital Management
GILD icon

Westfield Capital Management’s Gilead Sciences GILD Stock Holding History

Westfield Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.72M Sell
26,690
-14,825
-36% -$2.08M 0.02% 212
2025
Q4 		$5.1M Buy
+41,515
New +$5.05M 0.02% 211
2024
Q1 		– Sell
-100,981
Closed -$8.18M – 250
2023
Q4 		$8.18M Buy
100,981
+2,093
+2% +$163K 0.05% 193
2023
Q3 		$7.41M Buy
98,888
+6,137
+7% +$472K 0.05% 183
2023
Q2 		$7.15M Buy
92,751
+5,991
+7% +$478K 0.05% 184
2023
Q1 		$7.2M Buy
86,760
+3,165
+4% +$262K 0.05% 187
2022
Q4 		$7.18M Buy
83,595
+4,666
+6% +$370K 0.06% 183
2022
Q3 		$4.87M Sell
78,929
-2,326
-3% -$147K 0.04% 195
2022
Q2 		$5.02M Buy
+81,255
New +$5.03M 0.04% 199
2017
Q2 		– Sell
-45,465
Closed -$3.09M – 263
2017
Q1 		$3.09M Sell
45,465
-1,356,514
-97% -$95.4M 0.03% 235
2016
Q4 		$100M Sell
1,401,979
-130,839
-9% -$9.73M 0.88% 27
2016
Q3 		$121M Buy
+1,532,818
New +$125M 0.98% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Westfield Capital Management's GILD Position: Q1 2026 in Review

Westfield Capital Management reduced its Gilead Sciences (GILD) stake by 36% in Q1 2026, selling an estimated $2.08M and leaving 26,690 shares worth $3.72M. The position accounts for 0.02% of the portfolio, ranked #212.

Westfield Capital Management first reported a position in GILD in Q3 2016 and has held it in 12 quarters since. The position peaked at $121M in Q3 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Westfield Capital Management held 26,690 shares of Gilead Sciences worth $3.72M as of Q1 2026.
  • Westfield Capital Management sold 14,825 Gilead Sciences shares in Q1 2026, an estimated $2.08M.
  • Gilead Sciences made up 0.02% of Westfield Capital Management's portfolio in Q1 2026, its #212 holding.
  • Westfield Capital Management first reported a position in Gilead Sciences in Q3 2016 and has held it in 12 quarters since.
  • Westfield Capital Management's Gilead Sciences position peaked at $121M in Q3 2016.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Westfield Capital Management's 13F filing for Q1 2026, filed 11 May 2026.